Tekla Life Sciences Stock Probability of Future Stock Price Finishing Over 19.19

HQL Stock  USD 13.65  0.13  0.96%   
Tekla Life's future price is the expected price of Tekla Life instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Tekla Life Sciences performance during a given time horizon utilizing its historical volatility. Check out Tekla Life Backtesting, Tekla Life Valuation, Tekla Life Correlation, Tekla Life Hype Analysis, Tekla Life Volatility, Tekla Life History as well as Tekla Life Performance.
  
Price Earnings Ratio is expected to rise to 14.12 this year, although the value of Price To Sales Ratio will most likely fall to 15.52. Please specify Tekla Life's target price for which you would like Tekla Life odds to be computed.

Tekla Life Target Price Odds to finish over 19.19

The tendency of Tekla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 19.19  or more in 90 days
 13.65 90 days 19.19 
close to zero percent
Based on a normal probability distribution, the odds of Tekla Life to move over $ 19.19  or more in 90 days from now is close to zero percent (This Tekla Life Sciences probability density function shows the probability of Tekla Stock to fall within a particular range of prices over 90 days) . Probability of Tekla Life Sciences price to stay between its current price of $ 13.65  and $ 19.19  at the end of the 90-day period is about 36.94 .
Considering the 90-day investment horizon Tekla Life has a beta of 0.63. This usually indicates as returns on the market go up, Tekla Life average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tekla Life Sciences will be expected to be much smaller as well. Additionally Tekla Life Sciences has an alpha of 0.0186, implying that it can generate a 0.0186 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Tekla Life Price Density   
       Price  

Predictive Modules for Tekla Life

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tekla Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tekla Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.6713.5014.33
Details
Intrinsic
Valuation
LowRealHigh
12.7013.5314.36
Details
Naive
Forecast
LowNextHigh
12.8513.6814.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13.4713.5213.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tekla Life. Your research has to be compared to or analyzed against Tekla Life's peers to derive any actionable benefits. When done correctly, Tekla Life's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tekla Life Sciences.

Tekla Life Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Tekla Life is not an exception. The market had few large corrections towards the Tekla Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tekla Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tekla Life within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.02
β
Beta against NYSE Composite0.63
σ
Overall volatility
0.24
Ir
Information ratio -0.03

Tekla Life Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tekla Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tekla Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years
Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Latest headline from finance.yahoo.com: abrdn Healthcare Investors , abrdn Life Sciences Investors , abrdnHealthcare Opportunities Fund , and abrdn World Healthcare Fund Announce Investment Team Update

Tekla Life Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tekla Stock often depends not only on the future outlook of the current and potential Tekla Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tekla Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding26.8 M
Cash And Short Term Investments477.00

Tekla Life Technical Analysis

Tekla Life's future price can be derived by breaking down and analyzing its technical indicators over time. Tekla Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tekla Life Sciences. In general, you should focus on analyzing Tekla Stock price patterns and their correlations with different microeconomic environments and drivers.

Tekla Life Predictive Forecast Models

Tekla Life's time-series forecasting models is one of many Tekla Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tekla Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Tekla Life Sciences

Checking the ongoing alerts about Tekla Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tekla Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years
Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Latest headline from finance.yahoo.com: abrdn Healthcare Investors , abrdn Life Sciences Investors , abrdnHealthcare Opportunities Fund , and abrdn World Healthcare Fund Announce Investment Team Update
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out Tekla Life Backtesting, Tekla Life Valuation, Tekla Life Correlation, Tekla Life Hype Analysis, Tekla Life Volatility, Tekla Life History as well as Tekla Life Performance.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Tekla Stock analysis

When running Tekla Life's price analysis, check to measure Tekla Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Life is operating at the current time. Most of Tekla Life's value examination focuses on studying past and present price action to predict the probability of Tekla Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Life's price. Additionally, you may evaluate how the addition of Tekla Life to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Tekla Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Dividend Share
1.3
Earnings Share
0.79
Revenue Per Share
0.134
Quarterly Revenue Growth
0.344
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.